Literature DB >> 3312027

[Resistance pattern of clinical bacterial isolates. Results of a super-regional multicenter study of the Resistance Study Committee of the Paul Ehrlich Society of Chemotherapy].

M Kresken1, B Wiedemann.   

Abstract

In a multicentre study conducted by the Paul-Ehrlich-Gesellschaft we tested about 3,584 clinical isolates from 25 laboratories towards different chemotherapeutics. Using a microdilution test Enterobacteriaceae, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecalis strains regarded as causative pathogens were studied. The data were evaluated for the number, frequency and qualitative characteristics of multiple resistance patterns. None of the strains under test was resistant to all antibiotics tested. Amikacin showed the lowest prevalence of resistance. The significance of such data in the epidemiological control of resistance to chemotherapeutics is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312027     DOI: 10.1007/BF01645862

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  3 in total

1.  Development of resistance in the past decade in central Europe.

Authors:  M Kresken; B Wiedemann
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

2.  Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982.

Authors:  B A Atkinson; V Lorian
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

3.  [The propagation of aminoglycoside transferases in gram negative bacteria].

Authors:  B Wiedemann; G Tetzlaff; U van Treeck
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-03
  3 in total
  4 in total

1.  Clinical and radiological profile of posterior cortical atrophy and comparison with a group of typical Alzheimer disease and amnestic mild cognitive impairment.

Authors:  Gautam Das; Souvik Dubey; Uma Sinharoy; Adreesh Mukherjee; Sourav Banerjee; Durjoy Lahiri; Atanu Biswas
Journal:  Acta Neurol Belg       Date:  2020-11-23       Impact factor: 2.396

Review 2.  An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.

Authors:  Nicholas J Ashton; Abdul Hye; Anto P Rajkumar; Antoine Leuzy; Stuart Snowden; Marc Suárez-Calvet; Thomas K Karikari; Michael Schöll; Renaud La Joie; Gil D Rabinovici; Kina Höglund; Clive Ballard; Tibor Hortobágyi; Per Svenningsson; Kaj Blennow; Henrik Zetterberg; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2020-04-22       Impact factor: 42.937

3.  Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline.

Authors:  Julia Stockmann; Inge M W Verberk; Charlotte E Teunissen; Klaus Gerwert; Nina Timmesfeld; Robin Denz; Brian Budde; Julia Lange-Leifhelm; Philip Scheltens; Wiesje M van der Flier; Andreas Nabers
Journal:  Alzheimers Res Ther       Date:  2020-12-24       Impact factor: 6.982

Review 4.  Systematic Review of Different Neuroimaging Correlates in Mild Cognitive Impairment and Alzheimer's Disease.

Authors:  Puneet Talwar; Suman Kushwaha; Monali Chaturvedi; Vidur Mahajan
Journal:  Clin Neuroradiol       Date:  2021-07-23       Impact factor: 3.649

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.